Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.
Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations
The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.
EVEN MORE SEMINARS
Ali Gibson Stoke Mandeville Spinal Research
Spinal Cord Injury; the unseen complex complications – Neuropathic Pain
Dr Adrian Parry-Jones, Emily Birleson, Dr Camilla Sammut-Powell Greater Manchester Connected Health City
A learning health system for stroke in Greater Manchester
Dr Martine Stoffels Priory Brain Injury Services & Phoenix Mental Health Services
r-TMS in neuropsychiatric conditions.
Nilofar Niazi TRAINM
Case Study in Use of Technologies and Innovations in NeuroRehabilitation
SARA DA SILVA RAMOS The Disabilities Trust
Turning the tables in brain injury rehabilitation: Digitalisation and clinical data to inform service development